Structural remodeling in atrial fibrillation
- PMID: 18852714
- DOI: 10.1038/ncpcardio1370
Structural remodeling in atrial fibrillation
Abstract
Atrial fibrillation occurs and maintains itself in the context of a morphologically and functionally altered atrial substrate that can be induced by stressors such as underlying diseases (cardiac or noncardiac) or aging. The resultant structural remodeling is a slow process that progressively affects myocytes and the myocardial interstitium, and takes place from as early as the first days of atrial tachyarrhythmia. The left atrium, and particularly its posterior wall, is the location where remodeling is concentrated to the greatest extent. The mechanisms that underlie the remodeling process in atrial fibrillation have not yet been completely elucidated, although experimental and clinical investigations have indicated a number of signaling systems, inflammation, oxidative stress, atrial stretching and ischemia as factors involved in the cascade of events that leads to atrial fibrillation. The aim of this Review is to provide a comprehensive overview of the morphological changes that characterize the fibrillating atrial myocardium at histological and ultrastructural levels, and the established and hypothetical pathogenetic mechanisms involved in structural remodeling. This article also highlights the emerging therapies being developed to prevent progression of atrial fibrillation.
Similar articles
-
Mechanisms of atrial remodeling and clinical relevance.Curr Opin Cardiol. 2005 Jan;20(1):21-5. Curr Opin Cardiol. 2005. PMID: 15596955 Review.
-
Atrial structural remodeling as an antiarrhythmic target.J Cardiovasc Pharmacol. 2008 Jul;52(1):4-10. doi: 10.1097/FJC.0b013e3181668057. J Cardiovasc Pharmacol. 2008. PMID: 18594481 Review.
-
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.J Am Coll Cardiol. 2008 Feb 26;51(8):802-9. doi: 10.1016/j.jacc.2007.09.064. J Am Coll Cardiol. 2008. PMID: 18294563 Review.
-
[Morphological remodeling in atrial fibrillation].Herz. 2006 Apr;31(2):101-7; quiz 142-3. doi: 10.1007/s00059-006-2788-8. Herz. 2006. PMID: 16738831 Review. German.
-
Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.Circ Res. 2009 Dec 4;105(12):1213-22. doi: 10.1161/CIRCRESAHA.108.183400. Epub 2009 Oct 29. Circ Res. 2009. PMID: 19875729
Cited by
-
The matricellular protein CCN5 prevents adverse atrial structural and electrical remodelling.J Cell Mol Med. 2020 Oct;24(20):11768-11778. doi: 10.1111/jcmm.15789. Epub 2020 Sep 4. J Cell Mol Med. 2020. PMID: 32885578 Free PMC article.
-
Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation.Heart Rhythm. 2013 Jul;10(7):1001-9. doi: 10.1016/j.hrthm.2013.03.005. Epub 2013 Mar 14. Heart Rhythm. 2013. PMID: 23499625 Free PMC article.
-
Correlation Between CHA₂DS₂-VASc Scores and Left Atrial Measurements: A Single-Center Retrospective Study.Niger Med J. 2025 Jun 16;66(2):440-448. doi: 10.71480/nmj.v66i2.551. eCollection 2025 Mar-Apr. Niger Med J. 2025. PMID: 40703880 Free PMC article.
-
Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillation.Nat Cardiovasc Res. 2024 Sep;3(9):1067-1082. doi: 10.1038/s44161-024-00532-x. Epub 2024 Aug 23. Nat Cardiovasc Res. 2024. PMID: 39271815 Free PMC article.
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.Heart Rhythm. 2017 Jan;14(1):e3-e40. doi: 10.1016/j.hrthm.2016.05.028. Epub 2016 Jun 10. Heart Rhythm. 2017. PMID: 27320515 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical